Original articleParental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine
Section snippets
Methods
Online focus groups were conducted in January, 2015, with a U.S. national convenience sample of parents. A total of four focus groups were convened: two groups of parents of HPV unvaccinated daughters aged 9–12 years and two groups of parents of fully vaccinated daughters aged 11–17 years. This study focused on female vaccination as parental beliefs on vaccination may differ based on a child's sex; subsequent work should include parents of males. In addition, HPV9 has greater potential benefit
Demographic characteristics
The final sample consisted of 81 parents of 97 daughters. Forty-three were parents of fully vaccinated (three-dose completion) daughters; 38 were parents of unvaccinated daughters. The parents were diverse, representing 31 states and all nine U.S. Census regions [11]. The majorities of parents were female, had completed some college or obtained a college degree, were employed full time, and were married. See Table 2 for sociodemographic information on parents and daughters.
Qualitative analysis
Four main categories
Discussion
Consistent with other research on HPV vaccination, we found that most parents see HCP recommendation as among the most important factors in deciding about vaccination [12], [13], [14]. Parents clearly valued HCP expertise and expected their daughters' providers to be well informed about HPV9 and to be able to answer any questions that arise. It was notable, however, that there remained substantial gaps in knowledge and misunderstanding about the reasons for the recommendation to vaccinate all
Funding Sources
Support for this study was provided by Indiana University-Purdue University Center for HPV Research, which is funded by the Indiana University-Purdue University Signature Centers Initiative and the support of the IU School of Medicine, Department of Pediatrics and the IU Simon Cancer Center, and Boston College Internal Start-up Funds awarded to Dr. Fontenot.
References (19)
- et al.
Qualitative content analysis in nursing research: Concepts, procedures, and measures to achieve trustworthiness
Nurse Educ Today
(2004) - et al.
Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons
Vaccine
(2014) - et al.
The defining characteristics of Web 2.0 and their potential influence in the online vaccination debate
Vaccine
(2012) - et al.
Sorting through search results: A content analysis of HPV vaccine information online
Vaccine
(2012) - Centers for Disease Control and Prevention. Human papillomavirus (HPV). 2013. Available at:...
- U.S. Food and Drug Administration. June 8, 2006 Approval letter-human papillomavirus quadrivalent (types 6, 11, 16, 18)...
- U.S. Food and Drug Administration. October 16, 2009 Approval letter-Gardasil. Available at:...
FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee of Immunization Practices (ACIP)
MMWR Morb Mortal Wkly Rep
(2010)- U.S. Food and Drug Administration. News & events: FDA approves Gardasil 9 for prevention of certain cancers caused by...
Cited by (22)
Cancer Prevention Education for Providers, Staff, Parents, and Teens Improves Adolescent Human Papillomavirus Immunization Rates
2019, Journal of PediatricsCitation Excerpt :Such effects might impact vaccination rates among small groups of friends, but it is also feasible that larger scale influences could develop across those attending a particular school or to a larger number of teens living in the same community. A strong vaccine recommendation from a provider who is confident and knowledgeable about the HPV vaccine in addition to messages regarding HPV vaccine as cancer prevention motivates HPV vaccinations.38-40 Our multicomponent intervention was associated with small to moderate increases in HPV vaccination rates among the recruited practices.
Understanding the Two-Dose HPV Vaccine Schedule
2018, Nursing for Women's HealthCitation Excerpt :In addition, research should explore the impact of the two-dose schedule on U.S. vaccination rates. Authors of previous research highlighted the fact that parents believed that a 9vHPV two-dose schedule would be easier, more convenient, and less expensive and would facilitate vaccine dosing completion (Fontenot, Domush, & Zimet, 2015). However, despite these benefits, it is possible that nurses and other health care providers may experience difficulties transitioning from the three-dose to the two-dose schedule.
Parental acceptance of human papillomavirus vaccinations and community pharmacies as vaccination settings: A qualitative study in Alabama
2017, Papillomavirus ResearchCitation Excerpt :Disparities in knowledge also exist; parents of adolescents in rural areas are less aware of the HPV vaccine because they are less likely to be presented with the information [5,6]. Recommendations from healthcare professionals are key to HPV vaccine acceptability [7–10]. Interestingly, physicians do not rank the HPV vaccine as important when compared to other vaccines (Tdap and meningococcal vaccines) and often discuss the HPV vaccine last during patient visits [11].
Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine
2016, European Journal of CancerCitation Excerpt :The nonavalent vaccine may be seen by parents as going ‘back to square one’ in terms of the evidence of long-term efficacy, as it is newly developed. One online focus group study of parents of vaccinated and unvaccinated girls, conducted in the USA, identified concern about side-effects of the nonavalent vaccine [18]. Worry about possible long-term side-effects of first generation HPV vaccines is a well-established barrier to vaccine acceptance, and centres on the lack of long-term surveillance data due to the vaccine's novelty [14,15].
A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine
2016, VaccineCitation Excerpt :Most HCPs did not anticipate that parents or patients would have questions about 9vHPV. This finding is particularly interesting in light of a recent study by Fontenot et al. which found that parents had many questions about 9vHPV, including concerns about safety and whether yet another HPV vaccine might be developed in the near future [17]. However, the differences between what the providers in this study anticipated and what Fontenot et al. found could be due to different patient populations.